Sign in
4

Changes in Ownership

Atrium Therapeutics, Inc. Filed Acc 0001193125-26-170914

See Remarks acquired 102,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Kathleen P. See Remarks 2026-04-20 Grant or award +102,500 131,361 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Kathleen P. See Remarks 2026-04-20 Grant or award · Stock Option (Right to Buy) +205,000 205,000 D: show line 2 in the form
Loading xslF345X06/ownership.xml…